Recent advances in the treatment of childhood vitiligo

Expert Review of Dermatology

Volumn 3, Issue 6, 2008, Pages 691-699

  Berti, Samantha ^a   Lotti, Torello ^b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Children; Phototherapy; Treatment; UVB; Vitiligo

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETAMETHASONE VALERATE; CALCIPOTRIOL; CALCITRIOL RECEPTOR; CATALASE; CLOBETASOL PROPIONATE; CORTICOSTEROID; HERBACEOUS AGENT; PIMECROLIMUS; POLYPODIUM LEUCOTOMOS EXTRACT; PROSTAGLANDIN E2; PSEUDOCATALASE; PSORALEN; SUNSCREEN; TACROLIMUS; THIOCTIC ACID; UNCLASSIFIED DRUG; VITAMIN D DERIVATIVE;

ACNE; ANTIOXIDANT ACTIVITY; BALNEOTHERAPY; BURN; CANTALOUPE; CATARACT; CLINICAL TRIAL; DEPIGMENTATION; DOSE RESPONSE; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG RESPONSE; DRUG SAFETY; DRUG WITHDRAWAL; ERYTHEMA; EXCIMER LASER; HUMAN; HYPERPIGMENTATION; HYPERTRICHOSIS; INFECTION; ISOMORPHIC PHENOMENON; MELANOGENESIS; NAUSEA; ONSET AGE; PHOTOAGING; PHOTOTHERAPY; PRIORITY JOURNAL; PRURITUS; PSORIASIS; PUVA; RADIATION DOSE; REVIEW; ROSACEA; SCAR; SKIN ATROPHY; SKIN CANCER; SKIN DEFECT; SKIN GRAFT; SKIN IRRITATION; SKIN PROTECTION; STRIA; SUNBURN; TELANGIECTASIA; THERAPY EFFECT; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; UNSPECIFIED SIDE EFFECT; VITILIGO;

EID: 70049092968     PISSN: 17469872     EISSN: None     Source Type: Journal    
DOI: 10.1586/17469872.3.6.691     Document Type: Review

References (51)

1. Huggins RH, Schwartz RA, Janniger CK. Childhood vitiligo. Cutis 79(4), 277-280 (2007).
2. Lotti T, Gori A, Zanieri F et al. Vitiligo: new and emerging treatments. Dermatol. Ther. 21, 110-117 (2008).
3. Hu Z, Liu JB, Ma SS, Yang S, Zhang XJ. Profile of childhood vitiligo in China: an analysis of 541 patients. Pediatr. Dermatol. 23(2), 114-116 (2006).
4. Iacovelli P, Sinagra JL, Vidolin AP. Relevance of thryroiditis and other autoimmune diseases in children with vitiligo. Dermatology 210(1), 26-30 (2005).
5. Pajvani U, Ahmad N, Wiley A et al. The relationship between family medical history and childhood vitiligo. J. Am. Acad. Dermatol. 55(2), 238-244 (2006).
6. Lotti T, Prignano F, Buggiani G. New and experimental treatments of vitiligo and other hypomelanoses. Dermatol. Clin. 25(3), 393-400 (2007).
7. Hercogova J, Buggiani G, Prignano F, Lotti T. A rational approach to the treatment of vitiligo and other hypomelanoses. Dermatol. Clin. 25(3), 383-392 (2007).
8. Lotti T, Buggiani G, Troiano M et al. Targeted and combination treatments for vitiligo. Comparative evaluation of different current modalities in 458 subjects. Dermatol. Ther. (2008) (In press).
9. Forschner T, Buchholtz S, Stockfleth E. Current state of vitiligo therapy - evidence-based analysis of the literature. J. Dtsch. Dermatol. Ges. 5(6), 467-475 (2007).
10. Kwinter J, Pelletier J, Khambalia A, Pope E. High-potency steroid use in children with vitiligo: a retrospective study. J. Am. Acad. Dermatol. 56 (2), 236-241 (2007).
11. 2 stress. J. Invest. Dermatol. 122(2), 307-313 (2004).
12. Schallreuter KU. Effectiveness of pseudocatalase formulations in vitiligo. Clin. Exp. Dermatol. 28(5), 562-563 (2003).
13. Khemis A, Ortonne JP. Etude comparative d'un extrait vegetal possedand une activité superoxide dismutase (VITIX®) plus phototherapie UVB selective versus son excipient plus phototherapie selective dans le traitment du vitiligo vulgaire. Nouvelle Dermatologique 23, 7-11 (2004).
14. Dell'Anna ML, Mastrofrancesco A, Sala R et al. Antioxidants and narrow band UVB in the treatment of vitiligo: a double blind placebo controlled trial. Clin. Exp. Dermatol. 32(6), 631-636 (2007).
15. Middelkamp-Hup MA, Bos JD, Rius-Diaz F, Gonzales S, Westerhof W. Treatment of vitiligo vulgaris with narrow-band UVB and oral Polypodium leucotomos extract: a randomized trial double-blind placebo-controlled study. J. Eur. Dermatol. Venereol. 21(7), 942-950 (2007).
16. Grimes PE, Morris S, Avaniss-Aghajani E, Soriano T, Meraz M, Metzger A. Topical tacrolimus therapy for vitiligo: therapeutic responses and skin messenger RNA expression of proinflammatory cytokines. J. Am. Acad. Dermatol. 51(1), 52-61 (2004).
17. Passeron T, Ostovari N, Zakaria W et al. Topical tacrolimus and the 308 nm excimer laser. A synergistic combination for treatment of vitiligo. Arch. Dermatol. 140(9), 1065-1069 (2004).
18. Silverberg NB, Lin P, Travis L et al. Tacrolimus ointment promotes repigmentation of vitiligo in children: a review of 57 cases. J. Am. Acad. Dermatol. 51(5), 760-766 (2004).
19. Kanwar AJ, Dogra S, Parsad D. Topical tacrolimus for treatment of vitiligo in Asians. Clin. Exp. Dermatol. 29(6), 589-592 (2004).
20. Parsad D, Pandhi R, Dogra S, Kumas B. Topical prostaglandin analog (PGE2) in vitiligo: preliminary study. Int. J. Dermatol. 41(12), 942-945 (2002).
21. Travis LB, Silverberg NB. Calcipotriene and corticosteroid combination therapy for vitiligo. Pediatr. Dermatol. 21(4), 495-498 (2004).
22. Leone G, Pacifico A. Profile of clinical efficay and safety of topical tacalcitol. Acta Biomed. 76(1), 13-19 (2005).
23. Gargoom AM, Duweb GA, Elzorghany AH, Benghazil M, Bugrein OO. Calcipotriol in the treatment of childhood vitiligo. Int. J. Clin. Pharmacol. Res. 24(1), 11-14 (2004).
24. Kieffer MA. Topical vitamin D analogs. Dermatol. Nurs. 16(1), 89-90 (2004).
25. Parsad P, Pandhi R, Dogra S, Kumar B. Clinical study of repigmentation patterns with different treatment modalities and their correlation with speed and stability of repigmentation in 352 vitiliginous patches. J. Am. Acad. Dermatol. 50(1), 63-67 (2004).
26. Baysal W, Yildirim M, Erel A, Kesici D. Is the combination of calcipotriol and PUVA effective in vitiligo? J. Eur. Acad. Dermatol. Venereol. 17, 299-302 (2004).
27. Hirobe T. The role of keratinocytes derived factors involved in the proliferation and differentiation of mammalian epidermal melanocytes. Pigment Cell Res. 18(1), 2-12 (2005).
28. Westerhof W, Nieuweboer-Krobotova L. Treatment of vitiligo in UV-B radiation vs topical psoralen plus UV-A. Arch. Dermatol. 133(12), 1525-1528 (1997).
29. Njoo MD, Bos JD, Westerhof W. Treatment generalized vitiligo in children with narrow-band (TL-01) UVB radiation therapy. J. Am. Acad. Dermatol. 42(2 Pt 1), 245-253 (2000).
30. Kanwar AJ, Dogra S. Narrow-band UVB for the treatment of generalized vitiligo in children. Clin. Exp. Dermatol. 30(4), 332-336 (2005).
31. Kunisada M, Kumimoto H, Ishizaki K, Sakumi K, Nakabeppu Y, Nishigori C. Narrow-Band UVB induces more carcinogenic skin tumors than broad-band UVB through the formation of cyclobutane pyrimidine dimer. J. Invest. Dermatol. 127(12), 2865-2871 (2007).
32. Martin JA, Laube S, Edwards C, Gambles B, Anstey AV. Rate of acute adverse events for narrow-band UVB and psoralen-UVA phototherapy. Photodermatol. Photoimmunol. Photomed. 23(2-3), 68-72 (2007).
33. Menchini G, Tsoureli-Nikita E, Hercogova. Narrowband UV-B microphototherapy: a new treatment of vitiligo. J. Eur. Acad. Dermatol. Venereol. 17(2), 171-177 (2003).
34. Lotti T, Rossi R, Campolmi P. Targeted UV-B phototherapy: when and why to start. Arch. Dermatol. 142(7), 933-934 (2006).
35. Esposito M, Soda R, Costanzo A, Cimenti S. Treatment of vitiligo with the 308 nm excimer laser. Clin. Exp. Dermatol. 29(2), 133-137 (2004).
36. Passeron T, Ortonne JP. Use of the 308-nm excimer laser for psoriasis and vitiligo. Clin. Dermatol. 24(1), 33-42 (2006).
37. Passeron T, Ortonne JP. The 308 nm excimer laser in dermatology. Presse. Med. 34(4), 301-309 (2005).
38. Leone G, Iacovelli P, Paro Vidolin A, Picardo M. Monochromatic excimer light in the treatment of vitiligo: a pilot study. J. Eur. Acad. Dermatol. Venereol 17(5), 531-537 (2003).
39. Chimento SM, Newland M, Ricotti C, Nistico S, Romanelli P. A pilot study to determine the safety and the efficacy of monochromatic excimer light in the treatment of vitiligo. J. Drugs Dermatol. 7(3), 258-263 (2008).
40. Kollner K, Wimmershoff MB, Hintz C, Landthaler M, Hohenleutner U. Comaprison of 308-nm excimer laser and 308-nm excimer lamp with 311-nm narrowband ultraviolet B in the ttreatment of psoriasis. Br. J. Dermatol. 152(4) 750-754 (2005).
41. Siegfried E, Nopper AJ, Draelos Z, Bree A, Swords S, Laurer SJ. Principles of treatment in pediatric dermatology. Phototherapy. In: Pediatric Dermatology (3rd Edition). Schachner LA, Hansen RC (Eds). Mosby Elsevier Publishers, PA, USA 137-140 (2003).
42. Tanew A, Radakovic-Fijan S, Schemper M, Honigsmann H. Paired comparison study on narrow band (TL-01) UVB phototherapy versus photochemotherapy (PUVA) in the treatment of chronic plaque type psoriasis. Arch. Dermatol. 135, 519-524 (1999).
43. Mai DW, Omohundro C, Dijkstra JW, Bailin PL. Childhood vitiligo successfully treated with bath PUVA. Pediatr. Dermatol. 15(1), 53-55 (1998).
44. Chen YF, Yang PY, Hu DN, Kuo FS, Hung CS, Hung CM. Treatment of vitiligo by transplantation of cultured pure melanocyte suspension: analysis of 120 cases. J. Am. Acad. Dermatol. 51(1), 68-74 (2004).
45. Rusfianti M, Wirohadidjodjo YW. Dermosurgical techniques for repigmentation of vitiligo. Dermatol. Surg. 32(3), 387-391 (2006).
46. Gupta S, Kumar B. Epidermal grafting in vitiligo: influence of age, site of lesion, and type of disease on outcome. J. Am. Acad. Dermatol. 49(1), 99-104 (2003).
47. Leachman S. Surgical therapies. Part III. Melanocyte transplants. Dermatol. Ther. 14, 20-28 (2001).
48. Pianigiani E, Andreassi A, Andreassi L. Autografts and cultured epidermis in the treatment of vitiligo. Clin. Dermatol. 23(4), 424-429 (2005).
49. Andreassi A, Pianigiani E, Taddeucci P et al. Tissue-engineered skin in the treatment of vitiligo lesions. In: Vitiligo: Problems and Solutions. Lotti T, Hercogova J (Eds). Marcel Dekker, Inc., NY, USA 313-321 (2004).
50. Njoo MD, Vodegel RM, Westerhof W. Depigmentation therapy in vitiligo universalis with 4-methoxyphenol and Q-switched ruby laser. J. Am. Acad. Dermatol. 42(5 Pt 1), 760-769 (2000).
51. Radmanesh M. Depigmentation of the normally pigmented patches in universal vitiligo patients with cryotherapy. J. Eur. Acad. Dermatol. 14(3), 149-152 (2000).